Karine Hervé

Karine HERVÉ is a seasoned researcher with extensive experience in antibody discovery and engineering. Currently a Senior Research Scientist at AbCellera since February 2016, Karine has demonstrated a strong capability in developing and integrating new techniques into therapeutic antibody discovery pipelines. Previously, Karine contributed to UCB's Variable Region Discovery and Engineering group, focusing on humanizing therapeutic antibodies, and took on additional responsibilities in health, safety, and environment initiatives. Earlier experiences include roles at Roche, where development of antibody expression vectors was paramount, and Novartis, focusing on respiratory disease targets through RNA methodologies. Karine holds a Master's degree in Biotechnology from Aix-Marseille University and a technical degree from Lycée Technique Supérieur Marie-Curie in Marseille, France.